KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Short-term Investments (2016 - 2025)

Gilead Sciences' Short-term Investments history spans 16 years, with the latest figure at $68.0 million for Q4 2025.

  • For Q4 2025, Short-term Investments changed N/A year-over-year to $68.0 million; the TTM value through Dec 2025 reached $68.0 million, changed N/A, while the annual FY2025 figure was $68.0 million, N/A changed from the prior year.
  • Short-term Investments reached $68.0 million in Q4 2025 per GILD's latest filing, up from $19.0 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $1.6 billion in Q2 2021 to a low of $19.0 million in Q3 2025.
  • Average Short-term Investments over 4 years is $938.1 million, with a median of $973.0 million recorded in 2022.
  • Peak YoY movement for Short-term Investments: tumbled 87.59% in 2021, then increased 21.17% in 2023.
  • A 4-year view of Short-term Investments shows it stood at $1.2 billion in 2021, then dropped by 17.68% to $973.0 million in 2022, then rose by 21.17% to $1.2 billion in 2023, then tumbled by 94.23% to $68.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Short-term Investments are $68.0 million (Q4 2025), $19.0 million (Q3 2025), and $69.0 million (Q2 2025).